Chemotherapy
561 articles
No Time To Lose
Eduardo Servin acted pretty quickly when he began itching all over and noticed that he was jaundiced. He believes this saved his life.
Being Aggressive Paid Off
Lynn Perkins was only 42 when she was diagnosed with stage I pancreatic cancer, so she wanted aggressive treatment. That was in 2004!
A Long Slog to Diagnosis, A Quick Sprint to Surgery
Joseph Mele suffered through a year of mysterious GI symptoms until he was finally diagnosed with stage II pancreatic cancer.
Why Clinical Trials Should Be a Patient’s Starting Point
Why are clinical trials such an important part of pancreatic cancer treatment? We outline many reasons doctors and patients should look at trials.
A Cancer-Free Life 25 Years in the Making
Andy Lyons lost many family members to pancreatic cancer. With such a family history he knew to be proactive and get screened regularly.
Targeted Therapy for Cancers Carrying the PALB2 Mutation
Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation.
Progress in BRCA-Related Cancers Highlighted By the Basser Center
The Basser Center for BRCA hosted a panel discussion of the latest breakthroughs and discoveries for BRCA-related cancers.
Finding More Clues about Circulating Tumor DNA
Researcher Dr. Gehan Botrus looks at circulating tumor DNA for genetic information on a patient’s pancreatic cancer to personalize treatment.
What Happens When Pancreatic Cancer Clinical Trials Fail?
Why do clinical trials fail? What about the patients on the trial? Learn more about what happens when pancreatic cancer clinical trials fail.
Study Shows Fungi Boost Pancreatic Cancer Development and Growth
Drs. George Miller and Berk Aykut are leading research into the role of fungi in the growth and development of pancreatic cancer.
Platinum-Based Therapy Can Significantly Improve Survival for Some Pancreatic Cancer Patients
Dr. Michael Pishvaian explains how platinum-based therapy can improve the survival of pancreatic cancer patients with a specific mutation.
Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
Finding a Safe Dose of a New Drug for Some Types of Solid Tumors
LMB-100 is a lab-created protein that targets mesothelin. It is being tested against pancreatic cancer and other solid tumors in a clinical trial.
Treating BRCA-Negative Pancreatic Cancer Patients with a Family Cancer History Similar to BRCA Carriers
A clinical trial looks at the effectiveness of a PARP inhibitor in BRCA-negative pancreatic cancer patients with a family history BRCA-type cancers.
Drafting Your Health Care Team
If you have pancreatic cancer, a treatment team of experts from across the medical profession will make sure you get the best care.